Study Stopped
Sponsor decision.
VIA Disc NP Registry
1 other identifier
observational
83
1 country
32
Brief Summary
Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
Longer than P75 for all trials
32 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2020
CompletedFirst Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2024
CompletedMay 10, 2024
May 1, 2024
3.8 years
November 3, 2020
May 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient self-reporting of daily function
Change in scores from Oswestry Disability Index (ODI). An index comprising of ten categories of function to quantify disability due to back pain.
1, 3, 6, 12, 24, & 36 months
Patient self-reported back pain
Change in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).
1, 3, 6, 12, 24, & 36 months
Secondary Outcomes (2)
Patient self-reported mental health
1, 3, 6, 12, 24, & 36 months
Resource Utilization
1, 3, 6, 12, 24, & 36 months
Study Arms (1)
VIA Disc NP
Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment
Interventions
Eligibility Criteria
Registry will include at least 10,000 patients diagnosed with and treated for back pain across approximately 200 selected sites.
You may qualify if:
- years of age or older
- Understand and sign the informed consent form (as applicable)
- VIA Disc NP injection is scheduled for 1 or more levels
You may not qualify if:
- VIA Disc NP injection is not performed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (32)
Gateway Pain Solutions
Mesa, Arizona, 85206, United States
Source Healthcare
Santa Monica, California, 90403, United States
Interventional Pain Management
Walnut Creek, California, 94598, United States
MD Pain
Englewood, Colorado, 80112, United States
Western Rockies Interventional Pain Specialists
Grand Junction, Colorado, 81505, United States
The Denver Spine & Pain Institute
Greenwood Village, Colorado, 80111, United States
International Spine, Pain & Performance Center
Washington D.C., District of Columbia, 20006, United States
The Orthopedic Institute
Gainesville, Florida, 32607, United States
Southwest Florida Pain Center
Port Charlotte, Florida, 33948, United States
FAST MD
Tampa, Florida, 33609, United States
Florida Spine & Pain Specialists
Tampa, Florida, 33614, United States
Florida Pain Medicine
Wesley Chapel, Florida, 33544, United States
Orthopaedic Research Foundation
Indianapolis, Indiana, 46278, United States
Anesthesiology & Pain Consultants
Lafayette, Louisiana, 70508, United States
Interventional Pain Specialists
Opelousas, Louisiana, 70570, United States
Michigan Interventional Pain Center
Brownstown, Michigan, 48183, United States
Forest Health
Ypsilanti, Michigan, 48198, United States
Nevada Advanced Pain Specialists
Reno, Nevada, 89511, United States
Ainsworth Institute of Pain Management
New York, New York, 10022, United States
Premier Pain Solutions
Asheville, North Carolina, 28803, United States
Crystal Coast Pain Management
New Bern, North Carolina, 28560, United States
Premier Pain
Loveland, Ohio, 45140, United States
Invictus Healthcare System
Tulsa, Oklahoma, 74133, United States
Center for Interventional Pain Spine
Chadds Ford, Pennsylvania, 19317, United States
Atlantic Coast Pain Management
Conway, South Carolina, 29526, United States
Southeastern Spine Institute
Mt. Pleasant, South Carolina, 29464, United States
Specialist in Pain Management
Chattanooga, Tennessee, 37404, United States
Vertex Spine
Franklin, Tennessee, 37067, United States
Ortho Spine Surgery Institute
North Richland Hills, Texas, 76182, United States
MD SpineCare and DC Medical Solutions
San Antonio, Texas, 78229, United States
Advanced Spine and Pain Center
San Antonio, Texas, 78258, United States
The Sprintz Center for Pain
Shenandoah, Texas, 77384, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lisa Finstein, MHA
Vivex Biologics
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 36 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2020
First Posted
December 3, 2020
Study Start
May 3, 2020
Primary Completion
March 5, 2024
Study Completion
March 5, 2024
Last Updated
May 10, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share